到 2028 年北美护理点分子诊断市场预测 - 按产品和服务（检测和试剂盒、仪器、服务和软件）、技术（PCR、等温核酸扩增技术 (INAAT)）划分的 COVID-19 影响和区域分析和其他技术）、应用（传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用）、最终用户（医院和诊所、诊断实验室、研究和学术机构等）
No. of Pages: 165 | Report Code: TIPRE00026192 | Category: Life Sciences
No. of Pages: 165 | Report Code: TIPRE00026192 | Category: Life Sciences
市场介绍
即时分子诊断包括便携式设备以及检测和分析;用于检测和诊断人类样本中疾病的试剂盒，例如咽拭子、血液、血清和粪便。分子诊断正在从集中实验室转向分散的护理点分子测试。由于其简单、方便、周转时间短以及改善患者治疗效果的潜力，POCT 正在迅速获得关注。
此外，对消耗特定病毒检测方法的需求不断增长及时感染控制的时间减少预计将在预测期内促进市场增长。
美国是北美所有国家中 COVID-19 病例数量最多的国家。这对该地区的各个行业以及供应链和分销链产生了负面影响。在大流行期间，生命科学公司将重点转向开发治疗危及生命的疾病的新药。此外，对快速检测设备的需求也有所增加，这在北美即时分子诊断市场的增长中发挥着突出作用。此外，COVID-19 的持续传播正在增加对即时分子诊断试剂盒的需求。这些套件的采用正在促进新产品的开发和发布。 2021 年 3 月，Eurofins 旗下的 Clinical Enterprise, Inc. 获得了美国食品和药物管理局 (FDA) 的紧急使用授权 (EUA)，用于其 EmpowerDX COVID-19 家庭采集套件的直接面向消费者 (DTC) 版本。同样，2020 年 7 月，Eurofins USA 的临床诊断公司宣布推出聚合 PCR 检测来检测 SARS-CoV-2，这将大大降低客户每次 PCR 检测的成本。
市场概况和动态
北美即时分子诊断市场预计将达到到 2028 年，该市场的价值将从 2021 年的 8.609 亿美元增至 21.101 亿美元。预计从 2021 年到 2028 年，该市场将以 13.7% 的复合年增长率增长。持续的COVID-19大流行也为检测新型冠状病毒的POC分子诊断试剂盒制造商创造了机会。例如，全球医疗保健和医疗设备制造商雅培（ABBOTT）推出了ID NOW。它是一种分子即时护理仪器，可在五分钟内检测出新的冠状病毒感染。 ID NOW 是一种基于仪器的快速等温技术，用于定性检测传染病。其专有的等温核酸扩增产品和技术服务可在几秒钟内生成分子数据，使医生能够在患者就诊期间做出基于证据的治疗决策。 ID NOW 尚未获得美国食品和药物管理局 (FDA) 的认证或批准。它已获得 FDA 批准，可根据紧急使用授权 (EUA) 在授权实验室和患者护理机构中使用。此类创新和产品开发预计将为预测期内北美即时分子诊断市场的增长提供利润丰厚的机会。
主要细分市场
在产品和服务方面服务方面，检测和试剂盒细分市场在 2020 年北美床边护理分子诊断市场中占据最大份额。在技术方面，PCR 细分市场在北美床边护理分子诊断市场中占据最大份额2020年诊断市场。就应用而言，传染病细分市场在2020年北美即时分子诊断市场中占据最大份额。就最终用户而言，诊断实验室细分市场占据最大份额2020 年北美即时分子诊断市场。
主要来源和上市公司
准备本北美护理点分子诊断市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 BioMérieux SA、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Enzo Biochem, Inc.、Abbott、binx health, Inc.、Meridian BioScience, Inc.、Biocartis、Quidel Corporation 和Bio-Rad Laboratories, Inc.
购买报告的理由< /strong>
北美护理点分子诊断市场细分
按 产品和amp ;服务
按技术
作者应用
作者最终用户
按国家/地区
提及的公司
Strategic insights for North America Point-of-Care Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 860.9 Million |
| Market Size by 2028 | US$ 2,110.1 Million |
| Global CAGR (2021 - 2028) | 13.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品与服务
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Point-of-Care Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Point-of-Care Molecular Diagnostics Market is valued at US$ 860.9 Million in 2021, it is projected to reach US$ 2,110.1 Million by 2028.
As per our report North America Point-of-Care Molecular Diagnostics Market, the market size is valued at US$ 860.9 Million in 2021, projecting it to reach US$ 2,110.1 Million by 2028. This translates to a CAGR of approximately 13.7% during the forecast period.
The North America Point-of-Care Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Point-of-Care Molecular Diagnostics Market report:
The North America Point-of-Care Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Point-of-Care Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Point-of-Care Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Point-of-Care Molecular Diagnostics Market
